DSS Inc

DSS Inc(DSS)股票分析

$0.502

-0.006 (-1.20%)收盘时

Loading chart…
最高
0.536
开盘
0.512
成交量加权均价
0.51
成交量
12.36K
市值
12.39M
最低
0.502
成交额
6.35K
企业价值/息税折旧摊销前利润(TTM)
0.00

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

AI 分析 of DSS Inc (DSS)

卖出

DSS Inc is not a good buy right now due to its extremely low RSI of 11.84, indicating it is oversold, and a significant year-to-date change of -47.49%. The company is facing severe financial difficulties, with a gross margin of -25.39% in Q2 2026 and a net income loss of $4,789,000 in the same quarter. The main risk is the ongoing insider selling, with plans to sell $23.06 million in common stock, which could further depress the stock price.

估值指标

DSS Inc(DSS)当前预期市盈率为 0.00,5 年平均预期市盈率为 -1.42。

预期市盈率

高估
5 年均值 P/E
-1.42
当前P/E
0.00
高估
-0.57
低估
-2.27

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-5.88
当前EV/EBITDA
0.00
高估
1.04
低估
-12.81

预期市销率

低估
5 年均值 P/S
0.65
当前P/S
0.00
高估
1.03
低估
0.26

Alphio AI 对 DSS 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%DSS

$0.63

情景价格

基

基准

基准 · 50%DSS

$0.63

情景价格

悲

悲观

悲观 · 25%DSS

$0.61

情景价格

事件时间线

2026-09-04 (ET)

09:00:00

DSS, Inc. Cancels Proposed Public Offering

2026-09-03 (ET)

21:00:00

DSS Commences Public Offering of Common Stock

2026-05-08 (ET)

17:10:00

DSS Annual Report Contains Going Concern Audit Opinion

2026-02-04 (ET)

08:40:00

DSS Prices Public Offering Expected to Raise $1M

2026-02-03 (ET)

20:30:00

Aegis Capital Acts as Sole Underwriter for Offering

资讯

DSS 常见问题 —— 由 Alphio AI 解答

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).

DSS Inc is not a good buy right now due to its extremely low RSI of 11.84, indicating it is oversold, and a significant year-to-date change of -47.49%. The company is facing severe financial difficulties, with a gross margin of -25.39% in Q2 2026 and a net income loss of $4,789,000 in the same quarter. The main risk is the ongoing insider selling, with plans to sell $23.06 million in common stock, which could further depress the stock price.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易